한빛사논문 | BRIC

고재문 님의 논문 목록

서울대학교 의과대학

CV File 219 kb

Spatially resolved whole-transcriptomic and proteomic profiling of lung cancer and its immune-microenvironment according to PD-L1 expression
- Cancer Immunol. Res., Sep 05 2024, | https://doi.org/10.1158/2326-6066.CIR-24-0071
- 2024-09
- 의약학
- 한빛사논문
Transcriptomic heterogeneity of EGFR-mutant non-small cell lung cancer evolution towards small cell lung cancer
- Clin. Cancer Res., Aug 16 2024, | https://doi.org/10.1158/1078-0432.CCR-24-0160
- 2024-08
- 의약학
- 한빛사논문
Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration status
- Mod. Pathol., Published 17 July 2015 | https://doi.org/10.1038/modpathol.2015.63
- 2015-07
- 의약학
- 상위피인용논문
TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer
- Eur. J. Cancer, Volume 174, October 2022, Pages 10-20 | https://doi.org/10.1016/j.ejca.2022.07.004
- 2022-10
- 의약학
- 한빛사논문
Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19
- Cell Reports, Available online 20 September 2021, 109798 | https://doi.org/10.1016/j.celrep.2021.109798
- 2021-09
- 의약학
- 한빛사논문
IL-23-producing human lung cancer cells promote tumor growth via conversion of innate lymphoid cell 1 (ILC1) into ILC3
- Clin. Cancer Res., Published Online First April 12, 2019 | DOI: 10.1158/1078-0432.CCR-18-3458
- 2019-04
- 의약학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기